Brandon Price, DO
Family Medicine · Bismarck, NDNPI 1083710610
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (51.5%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Genentech USA, Inc. accounts for 95.2% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2023 at $3,085 and has fallen 97.7% since, to $70 in 2025. Among family medicine clinicians in ND with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 25 payments — averaging $170.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech USA, Inc.$4K
- Astellas Pharma US Inc$54
- Exact Sciences$32
- Amgen$28
- EMD Serono, Inc.$25
- Johnson & Johnson$24
- plus $39 from 2 others
What the payments were for
- Speaking & faculty fees$2,20052%
- Travel & lodging$1,65739%
- Food & beverage$41110%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech USA, Inc. | 14 | $4,064 |
| Astellas Pharma US Inc | 3 | $54 |
| Exact Sciences | 2 | $32 |
| Amgen | 2 | $28 |
| EMD Serono, Inc. | 1 | $25 |
| Johnson & Johnson | 1 | $24 |
| Abbott | 1 | $21 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OCREVUS$3,735
How this compares
$4,268 in reported general payments places this provider in the 90th percentile of 337 family medicine providers in North Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 19 | $509 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 55 | $415 |
| Doxycycline Hyclate | 77 | $399 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 52 | $369 |
| Mupirocin | 39 | $237 |
| Cephalexin | 46 | $214 |
| Prednisone | 126 | $200 |
| Levothyroxine Sodium | 14 | $196 |
| Atorvastatin Calcium | 12 | $162 |
| Azithromycin | 42 | $139 |
| Triamcinolone Acetonide | 22 | $113 |
| Dexamethasone | 18 | $66 |
| Fluconazole | 12 | $55 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 20 | $51 |
| Amoxicillin | 12 | $39 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Bismarck
- Jacqueline QuisnoBismarck$19K
- Jeffrey SmithBismarck$15K
- Stuart SmithBismarck$8K
- David PengillyBismarck$8K
- Biron BakerBismarck$8K
- Michelle TincherBismarck$7K
- Kevin LongieBismarck$6K
- Kelly LongieBismarck$5K
- Sherry SteinBismarck$5K
- David FieldBismarck$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.